185 related articles for article (PubMed ID: 26551887)
41. Differential contribution of the guanylyl cyclase-cyclic GMP-protein kinase G pathway to the proliferation of neural stem cells stimulated by nitric oxide.
Carreira BP; Morte MI; Lourenço AS; Santos AI; Inácio A; Ambrósio AF; Carvalho CM; Araújo IM
Neurosignals; 2013; 21(1-2):1-13. PubMed ID: 22378242
[TBL] [Abstract][Full Text] [Related]
42. Defects in cGMP-PKG pathway contribute to impaired NO-dependent responses in hepatic stellate cells upon activation.
Perri RE; Langer DA; Chatterjee S; Gibbons SJ; Gadgil J; Cao S; Farrugia G; Shah VH
Am J Physiol Gastrointest Liver Physiol; 2006 Mar; 290(3):G535-42. PubMed ID: 16269521
[TBL] [Abstract][Full Text] [Related]
43. ERK-dependent IL-6 autocrine signaling mediates adaptive resistance to pan-PI3K inhibitor BKM120 in head and neck squamous cell carcinoma.
Yun MR; Choi HM; Kang HN; Lee Y; Joo HS; Kim DH; Kim HR; Hong MH; Yoon SO; Cho BC
Oncogene; 2018 Jan; 37(3):377-388. PubMed ID: 28945228
[TBL] [Abstract][Full Text] [Related]
44. Human trabecular meshwork cell volume decrease by NO-independent soluble guanylate cyclase activators YC-1 and BAY-58-2667 involves the BKCa ion channel.
Dismuke WM; Sharif NA; Ellis DZ
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3353-9. PubMed ID: 19234350
[TBL] [Abstract][Full Text] [Related]
45. Elevated RET expression enhances EGFR activation and mediates EGFR inhibitor resistance in head and neck squamous cell carcinoma.
Lin C; Lu W; Ren Z; Tang Y; Zhang C; Yang R; Chen Y; Cao W; Wang L; Wang X; Ji T
Cancer Lett; 2016 Jul; 377(1):1-10. PubMed ID: 27090738
[TBL] [Abstract][Full Text] [Related]
46. Anti-cancer activity of a new dihydropyridine derivative, VdiE-2N, in head and neck squamous cell carcinoma.
Goto RN; Sobral LM; Sousa LO; Garcia CB; Lopes NP; Marín-Prida J; Ochoa-Rodríguez E; Verdecia-Reyes Y; Pardo-Andreu GL; Curti C; Leopoldino AM
Eur J Pharmacol; 2018 Jan; 819():198-206. PubMed ID: 29221949
[TBL] [Abstract][Full Text] [Related]
47. Targeting mTOR by CZ415 Inhibits Head and Neck Squamous Cell Carcinoma Cells.
Xie J; Li Q; Ding X; Gao Y
Cell Physiol Biochem; 2018; 46(2):676-686. PubMed ID: 29621758
[TBL] [Abstract][Full Text] [Related]
48. Regulation of p53 and suppression of apoptosis by the soluble guanylyl cyclase/cGMP pathway in human ovarian cancer cells.
Fraser M; Chan SL; Chan SS; Fiscus RR; Tsang BK
Oncogene; 2006 Apr; 25(15):2203-12. PubMed ID: 16288207
[TBL] [Abstract][Full Text] [Related]
49. Regulation of spontaneous contractile activity in the bovine epididymal duct by cyclic guanosine 5'-monophosphate-dependent pathways.
Mewe M; Bauer CK; Müller D; Middendorff R
Endocrinology; 2006 Apr; 147(4):2051-62. PubMed ID: 16439452
[TBL] [Abstract][Full Text] [Related]
50. Soluble guanylate cyclase stimulators in pulmonary hypertension.
Stasch JP; Evgenov OV
Handb Exp Pharmacol; 2013; 218():279-313. PubMed ID: 24092345
[TBL] [Abstract][Full Text] [Related]
51. Reduced proliferation and colony formation of head and neck squamous cell carcinoma (HNSCC) after dual targeting of EGFR and hedgehog pathways.
Liebig H; Günther G; Kolb M; Mozet C; Boehm A; Dietz A; Wichmann G
Cancer Chemother Pharmacol; 2017 Feb; 79(2):411-420. PubMed ID: 28110457
[TBL] [Abstract][Full Text] [Related]
52. Novel C-Terminal Heat Shock Protein 90 Inhibitors (KU711 and Ku757) Are Effective in Targeting Head and Neck Squamous Cell Carcinoma Cancer Stem cells.
Subramanian C; Kovatch KJ; Sim MW; Wang G; Prince ME; Carey TE; Davis R; Blagg BSJ; Cohen MS
Neoplasia; 2017 Dec; 19(12):1003-1011. PubMed ID: 29121598
[TBL] [Abstract][Full Text] [Related]
53. Cyclic GMP signaling in rat urinary bladder, prostate, and epididymis: tissue-specific changes with aging and in response to Leydig cell depletion.
Müller D; Mukhopadhyay AK; Davidoff MS; Middendorff R
Reproduction; 2011 Aug; 142(2):333-43. PubMed ID: 21511885
[TBL] [Abstract][Full Text] [Related]
54. Cyclic guanosine monophosphate modulates accumulation of phosphodiesterase 5 inhibitors in human platelets.
Bajraktari G; Burhenne J; Bugert P; Haefeli WE; Weiss J
Biochem Pharmacol; 2017 Dec; 145():54-63. PubMed ID: 28964803
[TBL] [Abstract][Full Text] [Related]
55. Livin enhances chemoresistance in head and neck squamous cell carcinoma.
Yoon TM; Kim SA; Lee DH; Lee JK; Park YL; Lee KH; Chung IJ; Joo YE; Lim SC
Oncol Rep; 2017 Jun; 37(6):3667-3673. PubMed ID: 28440463
[TBL] [Abstract][Full Text] [Related]
56. Galangin inhibits growth of human head and neck squamous carcinoma cells in vitro and in vivo.
Zhu L; Luo Q; Bi J; Ding J; Ge S; Chen F
Chem Biol Interact; 2014 Dec; 224():149-56. PubMed ID: 25450235
[TBL] [Abstract][Full Text] [Related]
57. Epidermal growth factor receptor-targeted therapy potentiates lovastatin-induced apoptosis in head and neck squamous cell carcinoma cells.
Mantha AJ; McFee KE; Niknejad N; Goss G; Lorimer IA; Dimitroulakos J
J Cancer Res Clin Oncol; 2003 Nov; 129(11):631-41. PubMed ID: 12942316
[TBL] [Abstract][Full Text] [Related]
58. cGMP-dependent protein kinase protects cGMP from hydrolysis by phosphodiesterase-5.
Kotera J; Grimes KA; Corbin JD; Francis SH
Biochem J; 2003 Jun; 372(Pt 2):419-26. PubMed ID: 12617722
[TBL] [Abstract][Full Text] [Related]
59. Role of sulfhydryl-dependent dimerization of soluble guanylyl cyclase in relaxation of porcine coronary artery to nitric oxide.
Zheng X; Ying L; Liu J; Dou D; He Q; Leung SW; Man RY; Vanhoutte PM; Gao Y
Cardiovasc Res; 2011 Jun; 90(3):565-72. PubMed ID: 21248051
[TBL] [Abstract][Full Text] [Related]
60. Antitumor activity of enzastaurin as radiation sensitizer in head and neck squamous cell carcinoma.
Yin X; Hayes DN; Shores CG
Head Neck; 2011 Aug; 33(8):1106-14. PubMed ID: 20967867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
